Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study

F Weeber; GA Cirkel; M Hoogstraat; Sander Bins; CGM Gadellaa-van Hooijdonk; WB Veldhuis; S Ooft; E van Werkhoven; SM Williems; M van Stralen; N J M Besselink; HM Horlings; N Steeghs; Maja de Jonge; M H G Langenberg; LFA Wessels; E Cuppen; JH Schellens; Stefan Sleijfer; Martijn Lolkema; EE Voest

doi:10.18632/oncotarget.16029

Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study

F Weeber, GA Cirkel, M Hoogstraat, Sander Bins, CGM Gadellaa-van Hooijdonk, WB Veldhuis, S Ooft, E van Werkhoven, SM Williems, M van Stralen, N J M Besselink, HM Horlings, N Steeghs, Maja de Jonge, M H G Langenberg, LFA Wessels, E Cuppen, JH Schellens, Stefan Sleijfer, Martijn LolkemaEE Voest

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

11 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	55582-55592
Number of pages	11
Journal	Oncotarget
Volume	8
Issue number	33
DOIs	https://doi.org/10.18632/oncotarget.16029
Publication status	Published - 2017

Research programs

EMC MM-03-86-08

Access to Document

10.18632/oncotarget.16029

REPUB_101893.pdfFinal published version, 943 KB

http://hdl.handle.net/1765/101893

Cite this

Weeber, F., Cirkel, GA., Hoogstraat, M., Bins, S., Gadellaa-van Hooijdonk, CGM., Veldhuis, WB., Ooft, S., van Werkhoven, E., Williems, SM., van Stralen, M., Besselink, N. J. M., Horlings, HM., Steeghs, N., de Jonge, M., Langenberg, M. H. G., Wessels, LFA., Cuppen, E., Schellens, JH., Sleijfer, S., ... Voest, EE. (2017). Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study. Oncotarget, 8(33), 55582-55592. https://doi.org/10.18632/oncotarget.16029

@article{36387285031a41b2adb32c87cb13c293,

title = "Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study",

author = "F Weeber and GA Cirkel and M Hoogstraat and Sander Bins and {Gadellaa-van Hooijdonk}, CGM and WB Veldhuis and S Ooft and {van Werkhoven}, E and SM Williems and {van Stralen}, M and Besselink, {N J M} and HM Horlings and N Steeghs and {de Jonge}, Maja and Langenberg, {M H G} and LFA Wessels and E Cuppen and JH Schellens and Stefan Sleijfer and Martijn Lolkema and EE Voest",

year = "2017",

doi = "10.18632/oncotarget.16029",

language = "Undefined/Unknown",

volume = "8",

pages = "55582--55592",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "33",

}

Weeber, F, Cirkel, GA, Hoogstraat, M, Bins, S, Gadellaa-van Hooijdonk, CGM, Veldhuis, WB, Ooft, S, van Werkhoven, E, Williems, SM, van Stralen, M, Besselink, NJM, Horlings, HM, Steeghs, N, de Jonge, M, Langenberg, MHG, Wessels, LFA, Cuppen, E, Schellens, JH, Sleijfer, S , Lolkema, M & Voest, EE 2017, 'Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study', Oncotarget, vol. 8, no. 33, pp. 55582-55592. https://doi.org/10.18632/oncotarget.16029

TY - JOUR

T1 - Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study

AU - Weeber, F

AU - Cirkel, GA

AU - Hoogstraat, M

AU - Bins, Sander

AU - Gadellaa-van Hooijdonk, CGM

AU - Veldhuis, WB

AU - Ooft, S

AU - van Werkhoven, E

AU - Williems, SM

AU - van Stralen, M

AU - Besselink, N J M

AU - Horlings, HM

AU - Steeghs, N

AU - de Jonge, Maja

AU - Langenberg, M H G

AU - Wessels, LFA

AU - Cuppen, E

AU - Schellens, JH

AU - Sleijfer, Stefan

AU - Lolkema, Martijn

AU - Voest, EE

PY - 2017

Y1 - 2017

U2 - 10.18632/oncotarget.16029

DO - 10.18632/oncotarget.16029

M3 - Article

C2 - 28903445

SN - 1949-2553

VL - 8

SP - 55582

EP - 55592

JO - Oncotarget

JF - Oncotarget

IS - 33

ER -